血管内皮成長因子-Cの持続的な供給のためのバイオマス由来リグニンナノ粒子

Ahmad Mavali Zadeh¹, Emanuela Gatto², Raffaella Lettieri²

¹Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Rome 00133, Italy.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

|September 6, 2025

まとめ

リグニンナノ粒子は血管内皮成長因子C (VEGFC) を効果的に提供し,リンパ腫のような疾患に対する新しい治療方法を提供します. これらのナノ粒子はタンパク質の放出を制御し治療の可能性を高めます

科学分野:

バイオマテリアル科学
ナノテクノロジー
再生医療

背景:

血管内皮成長因子C (VEGFC) は,心筋梗塞,神経変性疾患,リンパ腫の治療の可能性を示しています.
現在,VEGFCに対するアデノウイルスの遺伝子治療は,免疫不活性化による制限に直面しています.

研究の目的:

VEGFCのための新しい送達システムとして,リンニンナノ粒子 (LNP) を調査する.
VEGFCを積んだLNPを特徴付け,その放出運動と生物相容性を評価する.

主な方法:

オルガノ溶液法によるブドウ木のバイオマスからのリグニン抽出
ダイナミックな光散乱と顕微鏡を用いたLNPの合成と特徴付け.
VEGFCの負荷,放出プロファイル,プラズマ安定性,細胞活性の評価 (MTT測定法).

主要な成果:

合成されたLNPは,Z-Averageが143. 6nm,PDIが0. 126,ゼータポテンシャルが-41 ± 8mVであった.
効率的なVEGFC負荷と制御された放出が示されました.
LNPはVEGFCの放出を調節し,タンパク質は固有の安定性を示しています.

結論:

リグニンナノ粒子は,VEGFCの供給のための有望なプラットフォームです.
LNPの主な利点は,タンパク質の放出運動を制御する能力である.
このアプローチは様々な病気の治療結果を改善する可能性を秘めています

キーワード:

LNP についてリグニンリンパ腫ナノ粒子 VEGFC について

さらに関連する動画

07:42

Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids

Published on: March 1, 2024

859

09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

418

関連する概念動画

01:21

Paracrine Signaling

50.3K

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...

50.3K

01:10

Mechanism of Angiogenesis

6.4K

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

6.4K

01:24

Regulation of Angiogenesis and Blood Supply

2.9K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

2.9K

01:01

Regulation of Hematopoietic Stem Cells

3.5K

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

3.5K

01:28

Nitric Oxide Signaling Pathway

5.3K

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...

5.3K

01:28

Role of Hematopoietic Growth Factors

3.9K

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...